{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:10:42Z","timestamp":1779891042128,"version":"3.53.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00066-026-02524-1","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:19:36Z","timestamp":1776064776000},"page":"674-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consolidation radiotherapy refusal in stage\u00a0I\u2013II Hodgkin lymphoma: sociodemographic determinants and impact on survival outcomes"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-8110","authenticated-orcid":false,"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"2524_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115073","author":"C Rossi","year":"2024","unstructured":"Rossi\u00a0C, Manson\u00a0G, Marouf\u00a0A, Cabannes-Hamy\u00a0A, Nicolas-Virelizier\u00a0E, Maerevoet\u00a0M et\u00a0al (2024) Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines. European Journal of Cancer. https:\/\/doi.org\/10.1016\/j.ejca.2024.115073","journal-title":"European Journal of Cancer"},{"issue":"6","key":"2524_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","volume":"8","author":"LA Gloeckler Ries","year":"2003","unstructured":"Gloeckler Ries\u00a0LA, Reichman\u00a0ME, Lewis\u00a0DR, Hankey\u00a0BF, Edwards\u00a0BK (2003) Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8(6):541\u2013552. https:\/\/doi.org\/10.1634\/theoncologist.8-6-541","journal-title":"Oncologist"},{"key":"2524_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/107497","volume":"2011","author":"GK Singh","year":"2011","unstructured":"Singh\u00a0GK, Williams\u00a0SD, Siahpush\u00a0M, Mulhollen\u00a0A (2011) Socioeconomic, Rural-Urban, and Racial Inequalities in US Cancer Mortality: Part\u00a0I\u2014All Cancers and Lung Cancer and Part\u00a0II\u2014Colorectal, Prostate, Breast, and Cervical Cancers. J\u00a0Cancer Epidemiol 2011:107497. https:\/\/doi.org\/10.1155\/2011\/107497","journal-title":"J Cancer Epidemiol"},{"issue":"8","key":"2524_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","volume":"20","author":"MB Cook","year":"2011","unstructured":"Cook\u00a0MB, McGlynn\u00a0KA, Devesa\u00a0SS, Freedman\u00a0ND, Anderson\u00a0WF (2011) Sex Disparities in Cancer Mortality and Survival. Cancer Epidemiol Biomarkers Prev 20(8):1629\u20131637. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0246","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2524_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ijrobp.2017.07.016","volume":"99","author":"IM Krul","year":"2017","unstructured":"Krul\u00a0IM, van Winden\u00a0AWJO, Aleman\u00a0BMP, Janus\u00a0CPM, van Eggermond\u00a0AM, Bruin\u00a0MLD et\u00a0al (2017) Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure. International Journal of Radiation Oncology, Biology, Physics 99(4):843\u2013853. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.016","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"9","key":"2524_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2471\/BLT.21.287654","volume":"100","author":"IJ Borges do Nascimento","year":"2022","unstructured":"Borges do Nascimento\u00a0IJ, Pizarro\u00a0AB, Almeida\u00a0JM, Azzopardi-Muscat\u00a0N, Gon\u00e7alves\u00a0MA, Bj\u00f6rklund\u00a0M et\u00a0al (2022) Infodemics and health misinformation: a systematic review of reviews. Bull World Health Organ 100(9):544\u2013561. https:\/\/doi.org\/10.2471\/BLT.21.287654","journal-title":"Bull World Health Organ"},{"key":"2524_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54444-2","volume":"15","author":"S Li","year":"2024","unstructured":"Li\u00a0S, He\u00a0Y, Liu\u00a0J, Chen\u00a0K, Yang\u00a0Y, Tao\u00a0K et\u00a0al (2024) An umbrella review of socioeconomic status and cancer. Nat Commun 15:9993. https:\/\/doi.org\/10.1038\/s41467-024-54444-2","journal-title":"Nat Commun"},{"issue":"4","key":"2524_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz084","volume":"3","author":"S Karanth","year":"2019","unstructured":"Karanth\u00a0S, Fowler\u00a0ME, Mao\u00a0X, Wilson\u00a0LE, Huang\u00a0B, Pisu\u00a0M et\u00a0al (2019) Race, Socioeconomic Status, and Health-Care Access Disparities in Ovarian Cancer Treatment and Mortality: Systematic Review and Meta-Analysis. JNCI Cancer Spectr 3(4):pkz084. https:\/\/doi.org\/10.1093\/jncics\/pkz084","journal-title":"JNCI Cancer Spectr"},{"key":"2524_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-11129-2","volume":"24","author":"A Bourgeois","year":"2024","unstructured":"Bourgeois\u00a0A, Horrill\u00a0T, Mollison\u00a0A, Stringer\u00a0E, Lambert\u00a0LK, Stajduhar\u00a0K (2024) Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review. BMC Health Serv Res 24:670. https:\/\/doi.org\/10.1186\/s12913-024-11129-2","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"2524_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071067","volume":"17","author":"A Abdullah","year":"2025","unstructured":"Abdullah\u00a0A, Liu\u00a0Z, Molinari\u00a0M (2025) From Diagnosis to Survivorship: The Role of Social Determinants in Cancer Care. Cancers (Basel) 17(7):1067. https:\/\/doi.org\/10.3390\/cancers17071067","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2524_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1089\/jayao.2022.0109","volume":"12","author":"AG Hall","year":"2023","unstructured":"Hall\u00a0AG, Syrjala\u00a0KL, Ketterl\u00a0TG, Ganz\u00a0PA, Jacobs\u00a0LA, Palmer\u00a0SC et\u00a0al (2023) Socioeconomic Factors and Adherence to Health Care Recommendations in Adolescent and Young Adult Cancer Survivors. J\u00a0Adolesc Young Adult Oncol 12(5):701\u2013709. https:\/\/doi.org\/10.1089\/jayao.2022.0109","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2524_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211011956","volume":"28","author":"N Afshar","year":"2021","unstructured":"Afshar\u00a0N, English\u00a0DR, Milne\u00a0RL (2021) Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review. Cancer Control 28:10732748211011956. https:\/\/doi.org\/10.1177\/10732748211011956","journal-title":"Cancer Control"},{"issue":"11","key":"2524_CR13","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","volume":"2","author":"MV Maraldo","year":"2015","unstructured":"Maraldo\u00a0MV, Giusti\u00a0F, Vogelius\u00a0IR, Lundemann\u00a0M, van der Kaaij\u00a0MAE, Ramadan\u00a0S et\u00a0al (2015) Cardiovascular disease after treatment for Hodgkin\u2019s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. The Lancet Haematology 2(11):e492\u2013502. https:\/\/doi.org\/10.1016\/S2352-3026(15)00153-2","journal-title":"The Lancet Haematology"},{"key":"2524_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2022.10.003","volume":"177","author":"CG Patel","year":"2022","unstructured":"Patel\u00a0CG, Peterson\u00a0J, Aznar\u00a0M, Tseng\u00a0YD, Lester\u00a0S, Pafundi\u00a0D et\u00a0al (2022) Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations. Radiotherapy and Oncology 177:21\u201332. https:\/\/doi.org\/10.1016\/j.radonc.2022.10.003","journal-title":"Radiotherapy and Oncology"},{"issue":"9","key":"2524_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00066-015-0839-x","volume":"191","author":"J Kriz","year":"2015","unstructured":"Kriz\u00a0J, Spickermann\u00a0M, Lehrich\u00a0P, Schmidberger\u00a0H, Reinartz\u00a0G, Eich\u00a0H et\u00a0al (2015) Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin\u2019s lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT. Strahlenther Onkol 191(9):717\u2013725. https:\/\/doi.org\/10.1007\/s00066-015-0839-x","journal-title":"Strahlenther Onkol"},{"issue":"15","key":"2524_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153746","volume":"13","author":"P Loap","year":"2021","unstructured":"Loap\u00a0P, Mirandola\u00a0A, De Marzi\u00a0L, Dendale\u00a0R, Iannalfi\u00a0A, Vitolo\u00a0V et\u00a0al (2021) Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence. Cancers (Basel) 13(15):3746. https:\/\/doi.org\/10.3390\/cancers13153746","journal-title":"Cancers (Basel)"},{"issue":"15","key":"2524_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153744","volume":"13","author":"P Loap","year":"2021","unstructured":"Loap\u00a0P, De Marzi\u00a0L, Mirandola\u00a0A, Dendale\u00a0R, Iannalfi\u00a0A, Vitolo\u00a0V et\u00a0al (2021) Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives. Cancers (Basel) 13(15):3744. https:\/\/doi.org\/10.3390\/cancers13153744","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2524_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/0284186X.2021.2025265","volume":"61","author":"P Loap","year":"2022","unstructured":"Loap\u00a0P, Mirandola\u00a0A, De Marzi\u00a0L, Vitolo\u00a0V, Barcellini\u00a0A, Iannalfi\u00a0A et\u00a0al (2022) Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation. Acta Oncol 61(4):496\u2013499. https:\/\/doi.org\/10.1080\/0284186X.2021.2025265","journal-title":"Acta Oncol"},{"key":"2524_CR19","doi-asserted-by":"publisher","unstructured":"Loap\u00a0P, Goudjil\u00a0F, Dendale\u00a0R, Kirova\u00a0Y (2021) Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a\u00a0single-center early experience. Cancer RadiotherS1278\u20133218(21)00115\u20113. https:\/\/doi.org\/10.1016\/j.canrad.2021.06.016","DOI":"10.1016\/j.canrad.2021.06.016"},{"issue":"5","key":"2524_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ijrobp.2014.04.029","volume":"89","author":"BS Hoppe","year":"2014","unstructured":"Hoppe\u00a0BS, Flampouri\u00a0S, Zaiden\u00a0R, Slayton\u00a0W, Sandler\u00a0E, Ozdemir\u00a0S et\u00a0al (2014) Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a\u00a0Phase\u00a02\u00a0Study. International Journal of Radiation Oncology, Biology, Physics 89(5):1053\u20131059. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.029","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"32","key":"2524_CR21","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.21.00408","volume":"39","author":"DJ Cutter","year":"2021","unstructured":"Cutter\u00a0DJ, Ramroth\u00a0J, Diez\u00a0P, Buckle\u00a0A, Ntentas\u00a0G, Popova\u00a0B et\u00a0al (2021) Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography\u2013Directed Therapy for Early-Stage Hodgkin Lymphoma. J\u00a0Clin Oncol 39(32):3591\u20133601. https:\/\/doi.org\/10.1200\/JCO.21.00408","journal-title":"J Clin Oncol"},{"issue":"1","key":"2524_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00066-020-01682-0","volume":"197","author":"NB Pepper","year":"2021","unstructured":"Pepper\u00a0NB, Oertel\u00a0M, Kittel\u00a0C, Kr\u00f6ger\u00a0KJ, Elsayad\u00a0K, Haverkamp\u00a0U et\u00a0al (2021) Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin\u2019s lymphoma. Strahlenther Onkol 197(1):56\u201362. https:\/\/doi.org\/10.1007\/s00066-020-01682-0","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"2524_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jnci.2016.04.007","volume":"28","author":"C Higby","year":"2016","unstructured":"Higby\u00a0C, Khafaga\u00a0Y, Al-Shabanah\u00a0M, Mousa\u00a0A, Ilyas\u00a0M, Nazer\u00a0G et\u00a0al (2016) Volumetric-modulated arc therapy (VMAT) versus 3D-conformal radiation therapy in supra-diaphragmatic Hodgkin\u2019s Lymphoma with mediastinal involvement: A\u00a0dosimetric comparison. Journal of the Egyptian National Cancer Institute 28(3):163\u2013168. https:\/\/doi.org\/10.1016\/j.jnci.2016.04.007","journal-title":"Journal of the Egyptian National Cancer Institute"},{"key":"2524_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100335","author":"A Barcellini","year":"2021","unstructured":"Barcellini\u00a0A, Mas\u00a0FD, Paoloni\u00a0P, Loap\u00a0P, Cobianchi\u00a0L, Locati\u00a0L et\u00a0al (2021) Please mind the gap\u2014about equity and access to care in oncology. ESMO Open. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100335","journal-title":"ESMO Open"},{"key":"2524_CR25","doi-asserted-by":"publisher","unstructured":"Radkiewicz C, Bruchfeld JB, Weibull CE, Jeppesen ML, Frederiksen H, Lambe M, et\u00a0al. Sex differences in lymphoma incidence and mortality by subtype: A\u00a0population-based study. American Journal of Hematology. 2023;98(1):23\u201330. https:\/\/doi.org\/10.1002\/ajh.26744","DOI":"10.1002\/ajh.26744"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02524-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:58:16Z","timestamp":1779890296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02524-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2524"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02524-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.\u00a0Loap and Y.\u00a0Kirova declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}